1. Home
  2. AQST vs LYTS Comparison

AQST vs LYTS Comparison

Compare AQST & LYTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AQST
  • LYTS
  • Stock Information
  • Founded
  • AQST 2004
  • LYTS 1976
  • Country
  • AQST United States
  • LYTS United States
  • Employees
  • AQST N/A
  • LYTS N/A
  • Industry
  • AQST Biotechnology: Pharmaceutical Preparations
  • LYTS Building Products
  • Sector
  • AQST Health Care
  • LYTS Consumer Discretionary
  • Exchange
  • AQST Nasdaq
  • LYTS Nasdaq
  • Market Cap
  • AQST 502.6M
  • LYTS 480.6M
  • IPO Year
  • AQST 2018
  • LYTS N/A
  • Fundamental
  • Price
  • AQST $4.41
  • LYTS $20.07
  • Analyst Decision
  • AQST Strong Buy
  • LYTS Strong Buy
  • Analyst Count
  • AQST 7
  • LYTS 2
  • Target Price
  • AQST $9.43
  • LYTS $19.00
  • AVG Volume (30 Days)
  • AQST 1.7M
  • LYTS 128.8K
  • Earning Date
  • AQST 11-04-2024
  • LYTS 11-07-2024
  • Dividend Yield
  • AQST N/A
  • LYTS 1.00%
  • EPS Growth
  • AQST N/A
  • LYTS N/A
  • EPS
  • AQST N/A
  • LYTS 0.78
  • Revenue
  • AQST $58,900,000.00
  • LYTS $484,292,000.00
  • Revenue This Year
  • AQST $18.45
  • LYTS $16.63
  • Revenue Next Year
  • AQST N/A
  • LYTS $7.84
  • P/E Ratio
  • AQST N/A
  • LYTS $25.71
  • Revenue Growth
  • AQST 22.56
  • LYTS N/A
  • 52 Week Low
  • AQST $1.69
  • LYTS $12.53
  • 52 Week High
  • AQST $6.23
  • LYTS $21.17
  • Technical
  • Relative Strength Index (RSI)
  • AQST 37.69
  • LYTS 74.13
  • Support Level
  • AQST $4.62
  • LYTS $16.32
  • Resistance Level
  • AQST $5.59
  • LYTS $21.17
  • Average True Range (ATR)
  • AQST 0.37
  • LYTS 0.61
  • MACD
  • AQST -0.11
  • LYTS 0.31
  • Stochastic Oscillator
  • AQST 2.54
  • LYTS 77.51

About AQST Aquestive Therapeutics Inc.

Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Sympazan Oral Film, Suboxone Sublingual Film, Exservan Oral Film, and Zuplenz. The product pipeline includes Libervant Buccal Film, AQST-108, and AQST-305. The majority of its revenue comes from the United States.

About LYTS LSI Industries Inc.

LSI Industries Inc provides corporate visual image solutions to the petroleum and convenience store industry. The company's operating segments include Lighting and Display Solutions. It generates maximum revenue from the Lighting segment. Lighting Segment manufactures and markets outdoor and indoor lighting and lighting controls for the commercial, industrial, and multi-site retail markets including the petroleum/convenience store, quick-service, and automotive markets. The Display Solutions Segment manufactures, sells and installs exterior and interior visual image and display elements, including printed graphics, structural graphics, digital signage, menu board systems, display fixtures, refrigerated displays, and custom display elements.

Share on Social Networks: